Paolo Tombesi
2019 - INSMED
In 2019, Paolo Tombesi earned a total compensation of $1.5M as Former Chief Financial Officer at INSMED, a 25% decrease compared to previous year.
Compensation breakdown
| Option Awards | $974,990 |
|---|---|
| Salary | $189,958 |
| Other | $362,384 |
| Total | $1,527,332 |
Tombesi received $975K in option awards, accounting for 64% of the total pay in 2019.
Tombesi also received $190K in salary and $362.4K in other compensation.
Rankings
In 2019, Paolo Tombesi's compensation ranked 7,228th out of 13,971 executives tracked by ExecPay. In other words, Tombesi earned more than 48.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,228 out of 13,971 | 48th |
Division Manufacturing | 2,783 out of 5,701 | 51st |
Major group Chemicals And Allied Products | 1,036 out of 2,200 | 53rd |
Industry group Drugs | 881 out of 1,886 | 53rd |
Industry Pharmaceutical Preparations | 652 out of 1,398 | 53rd |
Source: SEC filing on March 31, 2020.
Tombesi's colleagues
We found six more compensation records of executives who worked with Paolo Tombesi at INSMED in 2019.
2019
William Lewis
INSMED
Chief Executive Officer
2019
Roger Adsett
INSMED
Chief Operating Officer
2019
Christine Pellizzari
INSMED
Chief Legal Officer
2019
S Schaeffer
INSMED
Chief People Strategy Officer
2019
John Goll
INSMED
Former Principal Financial Officer
2019
Martina Flammer
INSMED
Chief Medical Officer
News
Turning Point Therapeutics CEO Athena Countouriotis' 2021 pay rises 11% to $17M
April 29, 2022
Epizyme CEO Robert Bazemore's 2020 pay jumps 103% to $8.5M
April 29, 2021
Epizyme CEO Robert Bazemore's 2019 pay rises 14% to $4.2M
April 17, 2020
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019